Untitled

Loading Events

« All Webinars

“Site Protection, Securement & Skin Integrity: Skin Care Considerations for Vascular Access”

3M Health Care Academy* presents…“Site Protection, Securement & Skin Integrity: Skin Care Considerations for Vascular Access”

Prevention of infection, preservation of vascular access and promotion of patient comfort are key outcomes of care during infusion therapy. Because intact, healthy skin provides the body’s first line of defense, nurses providing infusion therapy need to have an understanding of skin and the mechanisms by which it can be disrupted. In this presentation, the participant will learn about normal skin structure and function, various types of Medical Adhesive-related Skin Injury (MARSI) as well as practical strategies for prevention and management of skin damage at vascular access sites.

Learning Objectives  |  At the end of this session, participants should be able to:

  1. Describe the significance of skin damage at vascular access sites
  2. Explain the mechanism of injury for at least 2 types of MARSI
  3. Describe four key steps for MARSI prevention

Speaker:

Debra Thayer, MS, RN, CWOCN  |  Lead Technical Service Specialist  |  3M Critical & Chronic Care Solutions Division

Target audience: Nursing, Central Service, Sterile Processing

Continuing Education Information  |  3M is an approved provider by The California Board of Registered Nursing. Provider Number CEP 5770. Each Device Reprocessing 1-hour web meeting is approved by IAHCSMM, CBSPD. These programs provide 1.0 CE contact hour.

Questions should be directed to 3M: 3MHealthCareAcademy@mmm.com

* NOTE: This is a contracted supplier-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.